Volume 91 Issue 16 | p. 19 | Concentrates
Issue Date: April 22, 2013

Bristol-Myers Plans Biologics Expansion

Department: Business
Keywords: biologics, manufacturing

Bristol-Myers Squibb will expand its large-scale biologics manufacturing facility in Devens, Mass. The $250 million project will add biologics development and clinical trial production capabilities to the four-year-old site with separate new buildings for each operation. The firm also plans to add 350 employees. “This project represents a significant expansion in both the size and mission of Devens,” says Peter Moesta, head of biologics manufacturing and process development.

You Do Not Have Access to C&EN Protected Content.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society